Generic Product News (July 2015)

Pharmacy Times, July 2015 Digestive Health, Volume 81, Issue 7

Read about the new generic products featured in July.

Gavis Pharmaceuticals LLC

Compare to: Methylin (Mallinckrodt)

Indication: Gavis Pharmaceuticals has launched methylphenidate hydrochloride (HCl) tablets, CII, a generic equivalent of Mallinckrodt’s Methylin. Methylphenidate HCl is a mild central nervous system stimulant that is indicated for the treatment of attention-deficit disorders and narcolepsy in patients 6 years and older. The treatment is contraindicated for patients with marked anxiety, tension, and agitation because the drug may aggravate these symptoms.

Dosage Form: Chewable tablets: 2.5, 5, and 10 mg

For More Information: www.gavispharma.com

Guanfacine Extended-Release Tablets Marketed by: Teva Pharmaceuticals

Compare to: Intuniv (Shire)

Indication: Teva Pharmaceuticals has launched guanfacine extended-release tablets, the generic equivalent of Shire’s Intuniv. Guanfacine extended-release tablets are a nonstimulant medication indicated for the treatment of attention-deficit/hyperactivity disorder. The drug can be used as monotherapy or as an adjunctive therapy to stimulant medications.

Dosage Form: Tablets: 1, 2, 3, and 4 mg

For More Information: www.tevagenerics.com

Risedronate Sodium Tablets, USPMarketed by: Teva Pharmaceuticals

Compare to: Actonel (Actavis Plc)

Indication: Teva Pharmaceuticals announced the launch of risedronate sodium tablets, the generic equivalent of Actonel by Actavis. Risedronate sodium tablets, USP, are indicated to treat or prevent postmenopausal osteoporosis by helping to increase bone mass and reduce the odds of a spinal or nonspinal fracture. The product is also used to treat or prevent osteoporosis in men and women who are also taking corticosteroid medications and to treat Paget’s disease of the bone.

Dosage Form: Tablets: 5, 30, and 35 mg

For More Information: www.tevagenerics.com

Famciclovir TabletsMarketed by: Camber Pharmaceuticals

Compare to: Famvir (Novartis)

Indication: Camber Pharmaceuticals has announced the launch of famciclovir tablets, the generic equivalent of Famvir by Novartis. Famciclovir tablet is a nucleoside analog DNA polymerase inhibitor indicated to treat recurrent episodes of both herpes labialis (cold sores) and genital herpes, and also as a suppressive therapy of recurrent episodes in patients 18 years and older.

Dosage Form: Tablets: 125, 250, and 500 mg

For More Information: www.camberpharma.com